Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

LLiminatus Pharma, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
L

Liminatus Pharma, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

No buy/sell activity
DateNameTitleSharesValueTransactionSource
Jul 2, 2026Valetudo Therapeutics LLCChief Executive Officer3,448,926Common Stock, par value $0.0001 per share$24.6MOther
Jun 24, 2026Valetudo Therapeutics LLCChief Executive Officer4,373,603Common Stock, par value $0.0001 per share$26.1MOther
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
$4.07Close ยท Sep 22, 2026